Selective antimicrobial modulation of human microbial flora.
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000517:prevention & control*; D003106:Colon / Q000382:microbiology*; D006801:Humans; D009268:Nalidixic Acid / Q000627:therapeutic use; D009503:Neutropenia / Q000150:complications; D010356:Patient Isolation
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid